European Companies Search Engine

EU funding (€3,434,981): Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease Hor23 Sept 2016 EU Research and Innovation programme "Horizon"

Text

The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Capital Medical University, Beijing, China.

Creative Commons License The visualizations for "China Capital Medical University - EU funding (€3,434,981): Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.